Crossmark

Y4 RNA fragments from cardiosphere-derived cells ameliorate diabetic myocardial ischemia‒reperfusion injury by inhibiting protein kinase C β-mediated macrophage polarization

Crossref DOI link: https://doi.org/10.1186/s12933-024-02247-6

Published Online: 2024-06-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, De-Zhao

Luo, Xiao-Zhi

Lu, Chuang-Hong

Feng, Yang-Yi

Chen, De-Xin

Zeng, Zhi-Yu

Huang, Feng
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82070279)

National Natural Science Foundation of China (82070279)

National Natural Science Foundation of China (82070279)

National Natural Science Foundation of China (82070279)

National Natural Science Foundation of China (82070279)

National Natural Science Foundation of China (82070279)

Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention (19-245-34)

Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention (19-245-34)

Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention (19-245-34)

Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention (19-245-34)

Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention (19-245-34)

Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention (19-245-34)

Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention (19-245-34)

Guangxi Clinical Research Center for Cardio Cerebrovascular Diseases (AD17129014)

Guangxi Clinical Research Center for Cardio Cerebrovascular Diseases (AD17129014)

Guangxi Clinical Research Center for Cardio Cerebrovascular Diseases (AD17129014)

Guangxi Clinical Research Center for Cardio Cerebrovascular Diseases (AD17129014)

Guangxi Clinical Research Center for Cardio Cerebrovascular Diseases (AD17129014)

Guangxi Clinical Research Center for Cardio Cerebrovascular Diseases (AD17129014)

Guangxi Clinical Research Center for Cardio Cerebrovascular Diseases (AD17129014)
License Information

Text and Data Mining valid from 2024-06-12

Version of Record valid from 2024-06-12
More Information

Article History

Received: 24 March 2024

Accepted: 22 April 2024

First Online: 12 June 2024

Declarations

:

: The authors of this study have no potential conflicts of interest.

Document is current

Any future updates will be listed below